ACORDA THERAPEUTICS INC's ticker is and the CUSIP is 00484MAA4. A total of 41 filers reported holding ACORDA THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $1,128,000 | -35.6% | 1,310,000 | -43.3% | 0.18% | -55.0% |
| Q4 2019 | $1,751,000 | -3.5% | 2,310,000 | 0.0% | 0.40% | -12.2% |
| Q3 2019 | $1,815,000 | -7.8% | 2,310,000 | 0.0% | 0.46% | -10.7% |
| Q2 2019 | $1,969,000 | -3.9% | 2,310,000 | 0.0% | 0.51% | -14.8% |
| Q1 2019 | $2,048,000 | +5.7% | 2,310,000 | 0.0% | 0.60% | -9.7% |
| Q4 2018 | $1,937,000 | -1.3% | 2,310,000 | 0.0% | 0.67% | +42.8% |
| Q3 2018 | $1,963,000 | -55.0% | 2,310,000 | -48.7% | 0.47% | -0.2% |
| Q2 2018 | $4,362,000 | -20.6% | 4,500,000 | -25.0% | 0.47% | +16.1% |
| Q1 2018 | $5,497,000 | +7.2% | 6,000,000 | 0.0% | 0.40% | -3.4% |
| Q4 2017 | $5,127,000 | -5.4% | 6,000,000 | 0.0% | 0.42% | -23.3% |
| Q3 2017 | $5,419,000 | +5.2% | 6,000,000 | 0.0% | 0.54% | -1.6% |
| Q2 2017 | $5,153,000 | +12.6% | 6,000,000 | 0.0% | 0.55% | +26.8% |
| Q4 2016 | $4,576,000 | – | 6,000,000 | – | 0.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opti Capital Management, LP | 7,500 | $6,276,000 | 2.99% |
| PFM Health Sciences, LP | 90,886,000 | $75,652,000 | 2.01% |
| Jabre Capital Partners S.A. | 1,750,000 | $1,474,000 | 1.68% |
| Partner Investment Management, L.P. | 1,108,000 | $922,000 | 1.15% |
| Telemetry Investments, L.L.C. | 2,000,000 | $1,655,000 | 1.06% |
| Worth Venture Partners, LLC | 1,562,000 | $1,312,000 | 0.99% |
| DLD Asset Management, LP | 12,000,000 | $10,028,000 | 0.69% |
| Castle Creek Arbitrage, LLC | 2,310,000 | $1,937,000 | 0.67% |
| CANYON CAPITAL ADVISORS LLC | 28,775,000 | $23,830,000 | 0.56% |
| SYMPHONY ASSET MANAGEMENT LLC | 2,000,000 | $1,665,000 | 0.49% |